Genetics of chronic lymphocytic leukaemia

Hematology and Cell Therapy

Volumn 42, Issue 1, 2000, Pages 5-14

  Kipps, T J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2;

CELL SURVIVAL; CHROMOSOME DELETION 13; CHRONIC LYMPHATIC LEUKEMIA; CONFERENCE PAPER; GENE DELETION; GENE MUTATION; GENETICS; MALIGNANT TRANSFORMATION; PHILADELPHIA 1 CHROMOSOME; PROGNOSIS; TRISOMY 12; TUMOR SUPPRESSOR GENE;

EID: 0033929516     PISSN: 12693286     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00282-000-0005-4     Document Type: Conference Paper

References (71)

1. Rowley JD (1973) A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243: 290-3
2. Padhy LC, Shih C, Cowing D, Finkelstein R, Weinberg RA (1982) Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas. Cell 28:865-71
3. Land H, Parada LF, Weinberg RA (1983) Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304:596-602
4. Dameshek W (1967) Chronic lymphocytic leukemia - an accumulative disease of immunologically incompetent lymphocytes. Blood 29:566-84
5. Rickinson AB, Finerty S, Epstein MA (1982) Interaction of EpsteinBarr virus with leukaemic B cells in vitro. I. Abortive infection and rare cell line establishment from chronic lymphocytic leukaemic cells. Clin Exp Immunol 50:347-54
6. Juliusson G, Oscier DG, Fitchett M, et al. (1990) Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med 323:720-4
7. Solé F, Woessner S, Perez-Losada A, et al. (1997) Cytogenetic studies in seventy-six cases of B-chronic lymphoproliferative disorders. Cancer Genet Cytogenet 93:160-6
8. Döhner H, Stilgenbauer S, Döhner K, Bentz M, Lichter P (1999) Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis. J Mol Med 77:266-81
9. Gardiner AC, Corcoran MM, Oscier DG (1997) Cytogenetic, fluorescence in situ hybridisation, and clinical evaluation of translocations with concomitant deletion at 13q14 in chronic lymphocytic leukaemia. Genes Chromosomes Cancer 20:73-81
10. Garcia-Marco JA, Caldas C, Price CM, Wiedemann LM, Ashworth A, Catovsky D (1996) Frequent somatic deletion of the 13q12.3 locus encompassing BRCA2 in chronic lymphocytic leukemia. Blood 88: 1568-75
11. Panayiotidis P, Ganeshaguru K, Rowntree C, Jabbar SA, Hoffbrand VA, Foroni L (1997) Lack of clonal BCRA2 gene deletion on chromosome 13 in chronic lymphocytic leukaemia. Br J Haematol 97:844-7
12. Garcia-Marco JA, Price CM, Catovsky D (1997) Interphase cytogenetics in chronic lymphocytic leukemia. Cancer Genet Cytogenet 94:52-8
13. Crossen PE (1997) Genes and chromosomes in chronic B-cell leukemia. Cancer Genet Cytogenet 94:44-51
14. Bouyge-Moreau I, Rondeau G, Avet-Loiseau H, et al. (1997) Construction of a 780-kb PAC, BAC, and cosmid contig encompassing the minimal critical deletion involved in B cell chronic lymphocytic leukemia at 13q14.3. Genomics 46:183-90
15. Corcoran MM, Rasool O, Liu Y, et al. (1998) Detailed molecular delineation of 13q14.3 loss in B-cell chronic lymphocytic leukemia. Blood 91:1382-90
16. Stilgenbauer S, Nickolenko J, Wilhelm J, et al. (1998) Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Oncogene 16:1891-7
17. Liu Y, Corcoran M, Rasool O, et al. (1997) Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia. Oncogene 15:2463-73
18. Kapanadze B, Kashuba V, Baranova A, et al. (1998) A cosmid and cDNA fine physical map of a human chromosome 13q14 region frequently lost in B-cell chronic lymphocytic leukemia and identification of a new putative tumor suppressor gene, Leu5. Febs Letters 426:266-70
19. Dierlamm J, Michaux L, Criel A, Wlodarska I, Van den Berghe H, Hossfeld DK (1997) Genetic abnormalities in chronic lymphocytic leukemia and their clinical and prognostic implications. Cancer Genet Cytogenet 94:27-35
20. Hjalmar V, Kimby E, Matutes E, et al. (1998) Trisomy 12 and lymphoplasmacytoid lymphocytes in chronic leukemic B-cell disorders. Haematologica 83:602-9
21. Losada AP, Wessman M, Tiainen M, et al. (1991) Trisomy 12 in chronic lymphocytic leukemia: an interphase cytogenetic study. Blood 78:775-9
22. Anastasi J, Le Beau MM, Vardiman JW, Fernald AA, Larson RA, Rowley JD (1992) Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: a simple and sensitive method. Blood 79:1796-1801
23. Que TH, Marco JG, Ellis J, et al. (1993) Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: analysis by stage, immunophenotype, and morphology. Blood 82:571-5
24. Acar H, Connor MJ (1998) Detection of trisomy 12 and centromeric alterations in CLL by interphase-and metaphase-FISH. Cancer Genet Cytogenet 100:148-51
25. Einhorn S, Burvall K, Juliusson G, Gahrton G, Meeker T (1989) Molecular analyses of chromosome 12 in chronic lymphocytic leukemia. Leukemia 3:871-4
26. Crossen PE, Horn HL (1987) Origin of trisomy 12 in B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet 28:185-6
27. Olivero M, Valente G, Bardelli A, et al. (1999) Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family. Int J Cancer 82:640-3
28. Qian L, Gong J, Liu J, Broome JD, Koduru PR (1999) Cyclin D2 promoter disrupted by t(12; 22)(p13; q11.2) during transformation of chronic lymphocytic leukaemia to non-Hodgkin's lymphoma. Br J Haematol 106:477-85
29. Ishwad CS, Shriver MD, Lassige DM, Ferrell RE (1997) The high mobility group I-C gene (HMGI-C): polymorphism and genetic localization. Human Genetics 99:103-5
30. Schwanbeck R, Manfioletti G, Wisniewski JR (2000) Architecture of high mobility group protein I-C.DNA complex and its perturbation upon phosphorylation by Cdc2 kinase. J Biol Chem 275: 1793-1801
31. Chau K, Arlotta P, Patel UA, Crane-Robinson C, Manfioletti G, Ono SJ (1999) A novel downstream positive regulatory element mediating transcription of the human high mobility group (HMG) I-C gene. Febs Letters 457:429-36
32. Woessner S, Sole F, Perez-Losada A, Florensa L, Vila RM (1996) Trisomy 12 is a rare cytogenetic finding in typical chronic lymphocytic leukemia. Leuk Res 20:369-74
33. Matutes E, Oscier D, Garcia-Marco J, et al. (1996) Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. Br J Haematol 92:382-8
34. Geisler CH, Philip P, Christensen BE, et al. (1997) In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: a cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients. Leuk Res 21:1011-23
35. H genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities. Blood 89:4153-60
36. Navarro B, Garcia-Marco JA, Jones D, Price CM, Catovsky D (1998) Association and clonal distribution of trisomy 12 and 13q14 deletions in chronic lymphocytic leukaemia. Br J Haematol 102:1330-4
37. Brynes RK, McCourty A, Sun NC, Koo CH (1995) Trisomy 12 in Richter's transformation of chronic lymphocytic leukemia. Am J Clin Pathol 104:199-203
38. Shahidi H, Leslie WT, Wool NL, Gregory SA (1997) Transformation of chronic lymphocytic leukemia to immunoblastic lymphoma (Richter's syndrome) [clinical conference]. Med Pediatr Oncol 29: 146-51
39. Garcia-Marco J, Matutes E, Morilla R, et al. (1994) Trisomy 12 in B-cell chronic lymphocytic leukaemia: assessment of lineage restriction by simultaneous analysis of immunophenotype and genotype in interphase cells by fluorescence in situ hybridization. Br J Haematol 87:44-50
40. Mould S, Gardiner A, Corcoran M, Oscier DG (1996) Trisomy 12 and structural abnormalities of 13q14 occurring in the same clone in chronic lymphocytic leukaemia. Br J Haematol 92:389-92
41. Oscier DG, Matutes E, Copplestone A, et al. (1997) Atypical lymphocyte morphology: an adverse prognostic factor for disease progression in stage A CLL independent of trisomy 12. Br J Haematol 98: 934-9
42. Criel A, Verhoef G, Vlietinck R, et al. (1997) Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases. Br J Haematol 97:383-91
43. Stilgenbauer S, Liebisch P, James MR, et al. (1996) Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-q23.1 in lymphoproliferative disorders. Proc Natl Acad Sci USA 93:11837-41
44. Döhner H, Stilgenbauer S, James MR, et al. (1997) 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood 89:2516-22
45. Karhu R, Knuutila S, Kallioniemi OP, et al. (1997) Frequent loss of the 11q14-24 region in chronic lymphocytic leukemia: a study by comparative genomic hybridization. Tampere CLL Group. Genes Chromosomes Cancer 19:286-90
46. Stilgenbauer S, Schaffner C, Litterst A, et al. (1997) Biallelic mutations in the ATM gene in T-prolymphocytic leukemia. Nature Med 3:1155-9
47. Yuille MR, Houlston RS, Catovsky D (1998) Anticipation in familial chronic lymphocytic leukaemia. Leukemia 12:1696-8
48. Stoppa-Lyonnet D, Soulier J, Laugé A, et al. (1998) Inactivation of the ATM gene in T-cell prolymphocytic leukemias. Blood 91: 3920-6
49. Luo L, Lu FM, Hart S, et al. (1998) Ataxia-telangiectasia and T-cell leukemias: no evidence for somatic ATM mutation in sporadic T-ALL or for hypermethylation of the ATM-NPAT/E14 bidirectional promoter in T-PLL [published erratum appears in Cancer Res 1998 Aug 1; 58(15):3488]. Cancer Res 58:2293-7
50. Lavin MF, Khanna KK (1999) ATM: the protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasia. Int J Radiat Biol 75:1201-14
51. Starostik P, Manshouri T, O'Brien S, et al. (1998) Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia. Cancer Res 58:4552-7
52. Bullrich F, Rasio D, Kitada S, et al. (1999) ATM mutations in B-cell chronic lymphocytic leukemia. Cancer Res 59:24-7
53. Bevan S, Yuille MR, Marossy A, Catovsky D, Houlston RS (1999) Ataxia telangiectasia gene mutations and chronic lymphocytic leukaemia. Lancet 353:753
54. Stankovic T, Weber P, Stewart G, et al. (1999) Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet 353:26-9
55. Zambetti GP, Levine AJ (1993) A comparison of the biological activities of wild-type and mutant p53. FASEBJ 7:855-65
56. Marshall CJ (1991) Tumor suppressor genes. Cell 64:313-26
57. Harris CC (1993) p53: at the crossroads of molecular carcinogenesis and risk assessment. Science 262:1980-1
58. Amiel A, Arbov L, Manor Y, et al. (1997) Monoallelic p53 deletion in chronic lymphocytic leukemia detected by interphase cytogenetics. Cancer Genet Cytogenet 97:97-100
59. Gaidano G, Ballerini P, Gong JZ, et al. (1991) p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 88: 5413-17
60. Fenaux P, Preudhomme C, Lai JL, et al. (1992) Mutations of the p53 gene in B-cell chronic lymphocytic leukemia: a report on 39 cases with cytogenetic analysis. Leukemia 6:246-50
61. Lens D, De Schouwer PJ, Hamoudi RA, et al. (1997) p53 abnormalities in B-cell prolymphocytic leukemia. Blood 89:2015-23
62. Cordone I, Masi S, Mauro FR, et al. (1998) p53 expression in B-cell chronic lymphocytic leukemia: a marker of disease progression and poor prognosis. Blood 91:4342-9
63. Callet-Bauchu E, Salles G, Gazzo S, et al. (1999) Translocations involving the short arm of chromosome 17 in chronic B-lymphoid disorders: frequent occurrence of dicentric rearrangements and possible association with adverse outcome. Leukemia 13:460-8
64. Adachi M, Tefferi A, Greipp PR, Kipps TJ, Tsujimoto Y (1990) Preferential linkage of bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia. J Exp Med 171:559-64
65. Raghoebier S, van Krieken JH, Kluin-Nelemans JC, et al. (1991) Oncogene rearrangements in chronic B-cell leukemia. Blood 77: 1560-4
66. Jonveaux P, Hillion J, Bennaceur AL, et al. (1992) t(14;18) and bcl-2 gene rearrangement in a B-chronic lymphocytic leukaemia. Br J Haematol 81:620-1
67. Pezzella F, Tse AG, Cordell JL, Pulford KA, Gatter KC, Mason DY. (1990) Expression of the bcl-2 oncogene protein is not specific for the 14:18 chromosomal translocation. Am J Pathol 137:225-32
68. Schena M, Larsson LG, Gottardi D, et al. (1992) Growth-and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells. Blood 79:2981-9
69. Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC (1993) Bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 82:1820-8
70. Laytragoon-Lewin N, Kashuba V, Mellstedt H, Klein G (1998) bcl-2 rearrangement detected by pulsed-field gel electrophoresis (PFGF) in B-chronic lymphocytic leukemia (CLL) cells. Int J Cancer 76: 909-12
71. Miyashita T, Reed JC (1993) Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81: 151-7